Salute e Benessere

Medical Connectors Market worth US$2.45 billion by 2030 with 7.1% CAGR |…

Browse in-depth TOC on "Medical Connectors Market" Browse in-depth TOC on "Medical Connectors Market" 320 - Tables50 - Figures300 - Pages By Based on Application,the medical connectors market is divided into eleven main segments based on application: patient monitoring devices, electrosurgical devices, diagnostic imaging devices, cardiology devices, analyzers & processing equipment, respiratory devices, dental instruments, endoscopy devices, neurology devices,...
PR Newswire
20/06/2025

With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack…

The global oncology market is expected to see strong growth over the next decade, with ResearchAndMarketsforecasting it to reach US$866.1 billion by 2034 at a 10.8% CAGR. A separate estimate from Vision Research Reportsprojects the market will surpass US$903.81 billion by the same year, growing at a 10.9% CAGR. The global oncology market is expected to see strong growth over the next decade, withResearchAndMarketsforecasting it to reachUS$866.1 billionby 2034 at a 10.8% CAGR. A...
PR Newswire
20/06/2025

AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – Amid the wave of new AI-powered innovations in healthcare, so far ambient scribes have emerged as the breakout use case. As the range of AI uses for the healthcare sector continues to grow, experts are analyzing the potential ROI on their implementation, and how much they'll benefit early adopters. Healthcare leaders are already seeing improvements, such as slashed clinician workloads from voice AI, and the adoption of…
PR Newswire
20/06/2025

EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of…

EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of Performance AI glasses for athletes and fans alikeThrough their long-term partnership, EssilorLuxottica and Meta will delivertheir second line of AI glasses with the Oakley brand, following Ray-Ban MetaParis, France and Menlo Park, California, 20 June 2025 – EssilorLuxottica and Meta Platforms announced Oakley Meta, a new category of Performance AI glasses that pair Meta’s industry-leading AI technology...
Nasdaq GlobeNewswire
20/06/2025

SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the…

– If approved, nirogacestat will be the first and only therapy with marketing authorization in the EU for the treatment of desmoid tumors –– Decision from European Commission expected in the third quarter of 2025 – STAMFORD, Conn., June20, 2025(GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the European Medicine Agency’s (EMA) Committee for Medicinal...
Nasdaq GlobeNewswire
20/06/2025

IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to…

Hanno Mak, Chief Executive Officer from AlfaRim, stated: "We are pleased to be part of this strategic collaboration with IONETIX. This collaboration is a significant step forward in our mission of making alpha therapies possible. This joint effort paves the way for a reliable and sustainable large-scale commercial supply of Ac-225." Hanno Mak, Chief Executive Officer from AlfaRim, stated: "We are pleased to be part of this strategic collaboration with IONETIX. This collaboration…
PR Newswire
20/06/2025

CHMP recommends third indication for darolutamide for patients with advanced…

ORION CORPORATIONPRESS RELEASE20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the marketing authorisation of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in the European Union.Positive opinion is based on results from the pivotal Phase III ARANOTE trial.Pending...
Nasdaq GlobeNewswire
20/06/2025

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated…

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy 1 ,2 Recommendation based on CABINET Phase III trial results, which demonstrated statistically significant and clinically meaningful reductions in risk of disease progression or death with Cabometyx versus placebo 3 ,4 European Commission decision...
Nasdaq GlobeNewswire
20/06/2025

The Department of Health - Abu Dhabi and Abbot Unite to Manufacture…

H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: "Following the recent launch of the Health, Endurance, Longevity and Medicine (HELM) Cluster in Abu Dhabi, the emirate proved to be equipped with a holistic, integrated infrastructure that fosters local manufacturing and R&D, positioning it as a regional healthcare gateway and leader in life sciences. By integrating our strategic vision with Abbott's expertise, we aim to accelerate the development…
PR Newswire
20/06/2025

VERSACE HOME UNVEILS ITS EIGHT HAUTE COUTURE VILLAS IN MARBELLA

Each villa, valued at over 10 million euros, offers an unparalleled residential experience, with more than 20 rooms spread across two floors on individual 2,000-square-meter plots. From the landscaped entrances to the heated pools, every detail has been designed to combine privacy, luxury, and design. The interiors, featuring customized Versace finishes, include spaces such as a spa, open-air cinema, and private gym. The common areas flow elegantly, incorporating sculptural stone, marble, rich…
PR Newswire
20/06/2025

BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING

As previously announced, the Company intends to consolidate the common shares of the Company (the "Common Shares") on the basis of ten (10) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the "Consolidation"), and complete a concurrent Offering consisting of a minimum of 5,714,285 Units at a post-Consolidation price of $0.35 per Unit for minimum gross proceeds of $2,000,000 and a maximum of 8,571,428 Units at a post-Consolidation price of $0.35…
PR Newswire
20/06/2025

Sobi will showcase extensive research and clinical outcomes at ISTH 2025

"We are proud to be showcasing abstracts as part of the ISTH programme, including Doptelet abstracts that present new data related to children living with ITP, Altuvoct outcomes for perioperative management, and joint health outcomes from a long-term extension study, as well as final outcomes from the B-MORE study. Many people living with rare conditions have unmet needs, and we are proud to present additional data advancing treatments for these rare conditions." "We are proud to…
PR Newswire
20/06/2025

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid…

Aesthetic Procedures Aesthetic Procedures Eyelid surgery, for the first time, was the most common surgical procedure in 2024, replacing liposuction, with 2.1 million, followed by liposuction, breast augmentation, scar revision, and rhinoplasty. The most popular non-surgical procedures were botulinum toxin, hyaluronic acid (filler), hair removal, non-surgical skin tightening, and chemical peels. Most face and head procedures showed growth from the previous year, with more than 7...
PR Newswire
20/06/2025

Press Release: Dupixent approved in the US as the only targeted medicine to…

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared to placebo in adults with BPBP is a chronic, debilitating, and relapsing rare skin disease affecting approximately 27,000 adults in the US whose disease is uncontrolled by systemic corticosteroidsDupixent is now approved in the US to treat...
Nasdaq GlobeNewswire
20/06/2025

Carbios presents the results of its Annual General Meeting of 19 June 2025 and…

Clermont-Ferrand (France), June 20, 2025 (6:45 am CEST).CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces the results of its Ordinary and Extraordinary general Meeting of June 19, 2025.Shareholders physically present, represented or voting by post totalled 31.18% of the shares composing the Company's share capital and carrying voting rights, and 31.25% of the...
Nasdaq GlobeNewswire
20/06/2025

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During…

Key Takeaways from the HER2-low Cancers Market Report Key Takeaways from the HER2-low Cancers Market Report Discover which therapies are expected to grab the HER2-low cancers market share @ HER2-low Cancers Market Report HER2-low Cancers Market Dynamics The HER2-low cancer market has recently garnered significant attention, primarily due to theadvancements in targeted therapiesfor cancers with low expression of the HER2 protein. While HER2-positive cancers, such as breast...
PR Newswire
19/06/2025

Delta-like Ligand 3 Targeted Therapies Market is Predicted to Heat Up During the…

Key Takeaways from the Delta-like Ligand 3 Targeted Therapies Market Report Key Takeaways from the Delta-like Ligand 3 Targeted Therapies Market Report Discover which indication is expected to grab the major delta-like ligand 3 targeted therapies market share @ Delta-like Ligand 3 Targeted Therapies Market Report Delta-like Ligand 3 Targeted Therapies Market Dynamics The delta-like ligand 3 targeted therapies market is emerging as a dynamic and promising area in oncology,...
PR Newswire
19/06/2025

Biological Safety Cabinets Market to Reach USD 448.4 Million by 2032, Driven by…

Browse the report and understand how it can benefit your business strategy - https://www.credenceresearch.com/report/biological-safety-cabinets-market Browse the report and understand how it can benefit your business strategy -https://www.credenceresearch.com/report/biological-safety-cabinets-market Key Growth Determinants – Biological Safety Cabinets Market Rising Focus on Laboratory Biosafety and Infection Control The heightened focus on laboratory biosafety is...
PR Newswire
19/06/2025

Zemcelpro® (UM171 Cell Therapy) receives positive CHMP opinion for treatment of…

If approved, Zemcelpro® is expected to be the first and only therapy in the EU with marketing authorization for adults with haematological malignancies requiring an allogeneic haematopoietic stem cell transplantation following myeloablative conditioning for whom no other type of suitable donor cells is available. Every year in Europe there are over 10,000 new cases of patients with haematological malignancies, including leukemias and myelodysplastic syndromes, requiring bone marrow transplant…
PR Newswire
19/06/2025

Pharmaceutical Membrane Filters Market Size to Surpass USD 20.05 Billion by…

The report from The Insight Partners provides several stakeholders—including manufacturers and end users—with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners provides several stakeholders—including manufacturers and end users—with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities. To explore the valuable insights in the Pharmaceutical Membrane...
PR Newswire
19/06/2025

Colonoscopy Devices Market Size to Surpass USD 3.36 Billion by 2031, exhibiting…

The report from The Insight Partners provides several stakeholders—including manufacturers of colonoscopes and visualization systems—with valuable insights to navigate this evolving market landscape and unlock new opportunities successfully. The report from The Insight Partners provides several stakeholders—including manufacturers of colonoscopes and visualization systems—with valuable insights to navigate this evolving market landscape and unlock new opportunities successfully. ...
PR Newswire
19/06/2025

Infusion Pump Market worth US$28.3 billion by 2030 with 7.4% CAGR |…

Browse in-depth TOC on "Infusion Pump Market" Browse in-depth TOC on "Infusion Pump Market" 420 - Tables 120 - Figures 500 - Pages By type,the accessories & consumables segment accounted for a larger market share in 2024. The substantial market share attributed to infusion pump disposables is primarily linked to their critical role in ensuring safe and effective medication administration through recurrent use. This category encompasses essential components such as...
PR Newswire
19/06/2025

Biodefense Market Size worth $22.8 billion, Globally, by 2030 with 5% CAGR -…

For More Information and To Stay Updated on The Latest Developments in The Biodefense Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=9969 For More Information and To Stay Updated on The Latest Developments in The Biodefense Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=9969 Market Overview and Growth Trajectory: Biodefense Market Growth: According to an exhaustive report by...
PR Newswire
19/06/2025

Dermoscopy and Skin Visualization Devices Market to Reach $3.3 Billion by 2035…

The growth of the dermoscopy and skin visualization devices market is mainly driven by a convergence of critical healthcare trends. The rising incidence of skin cancer and melanoma worldwide has created an urgent need for innovative diagnostic solutions that can enable early detection and improve patient outcomes. Simultaneously, significant advancements in optical imaging technology and smartphone integration have opened unprecedented possibilities for accessible dermatological diagnostics…
PR Newswire
19/06/2025
Altri  Comunicati